Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function

Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / metabolism
  • Drug Administration Schedule
  • Drugs, Investigational / administration & dosage*
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / metabolism
  • Female
  • Humans
  • Kidney Diseases / metabolism*
  • Liver Diseases / metabolism*
  • Male
  • Menogaril
  • Middle Aged
  • Nogalamycin / administration & dosage
  • Nogalamycin / adverse effects
  • Nogalamycin / analogs & derivatives*
  • Nogalamycin / metabolism
  • Prospective Studies

Substances

  • Antineoplastic Agents
  • Drugs, Investigational
  • Menogaril
  • Nogalamycin